AR004781A1 - Derivados de 2-(sulfanil substituido)-3,5-dihidro-imidazol-4-ona y su uso en la preparacionn de medicamentos. - Google Patents

Derivados de 2-(sulfanil substituido)-3,5-dihidro-imidazol-4-ona y su uso en la preparacionn de medicamentos.

Info

Publication number
AR004781A1
AR004781A1 ARP960105365A ARP960105365A AR004781A1 AR 004781 A1 AR004781 A1 AR 004781A1 AR P960105365 A ARP960105365 A AR P960105365A AR P960105365 A ARP960105365 A AR P960105365A AR 004781 A1 AR004781 A1 AR 004781A1
Authority
AR
Argentina
Prior art keywords
carbon atoms
medicines
dihydro
derivatives
preparation
Prior art date
Application number
ARP960105365A
Other languages
English (en)
Spanish (es)
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/563,841 external-priority patent/US5599829A/en
Application filed by American Home Prod filed Critical American Home Prod
Publication of AR004781A1 publication Critical patent/AR004781A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41661,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ARP960105365A 1995-11-28 1996-11-27 Derivados de 2-(sulfanil substituido)-3,5-dihidro-imidazol-4-ona y su uso en la preparacionn de medicamentos. AR004781A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US765395P 1995-11-28 1995-11-28
US08/563,841 US5599829A (en) 1995-11-28 1995-11-28 2-(substituted sulfanyl)-3,5-dihydro-imidazol-4-one derivatives for increasing HDL cholesterol levels

Publications (1)

Publication Number Publication Date
AR004781A1 true AR004781A1 (es) 1999-03-10

Family

ID=26677246

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP960105365A AR004781A1 (es) 1995-11-28 1996-11-27 Derivados de 2-(sulfanil substituido)-3,5-dihidro-imidazol-4-ona y su uso en la preparacionn de medicamentos.

Country Status (6)

Country Link
EP (1) EP0876354A1 (fr)
JP (1) JP2000514401A (fr)
AR (1) AR004781A1 (fr)
AU (1) AU1063497A (fr)
CA (1) CA2238812A1 (fr)
WO (1) WO1997019931A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2168576A3 (fr) 2001-09-14 2010-05-26 Shionogi & Co., Ltd. Composés tricycliques dans le traitement de la dyslipidémie et des maladies artériosclérotiques
ATE502298T1 (de) 2003-12-19 2011-04-15 Univ California Verfahren und materialien zur beurteilung von prostatakrebstherapien
NZ550102A (en) 2004-02-24 2010-10-29 Univ California Methods and materials for assessing prostate cancer therapies and compounds (thiohydantoine derivatives)
US7709517B2 (en) 2005-05-13 2010-05-04 The Regents Of The University Of California Diarylhydantoin compounds
SI2656842T1 (sl) 2006-03-27 2016-10-28 The Regents Of The University Of California Modulator androgenih receptorjev za zdravljenje raka prostate in bolezni, povezanih z androgenimi receptorji
WO2007127010A2 (fr) 2006-03-29 2007-11-08 The Regents Of The University Of California Composés de diarylthiohydantoïne
EP2620432A3 (fr) 2007-10-26 2013-12-18 The Regents Of the University of California Composés de diarylhydantoïne
AU2011218173C1 (en) 2010-02-16 2015-04-16 Aragon Pharmaceuticals, Inc. Androgen receptor modulators and uses thereof
NZ744456A (en) 2012-09-26 2019-09-27 Aragon Pharmaceuticals Inc Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer
PL2945628T3 (pl) 2013-01-15 2020-09-21 Aragon Pharmaceuticals, Inc. Modulator receptorów androgenowych w skojarzeniu z octanem abirateronu i prednizonem do leczenia nowotworu stercza
TWI726969B (zh) 2016-01-11 2021-05-11 比利時商健生藥品公司 用作雄性激素受體拮抗劑之經取代之硫尿囊素衍生物
US10702508B2 (en) 2017-10-16 2020-07-07 Aragon Pharmaceuticals, Inc. Anti-androgens for the treatment of non-metastatic castration-resistant prostate cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2694290B1 (fr) * 1992-07-08 1994-09-02 Roussel Uclaf Nouvelles phénylimidazolidines éventuellement substituées, leur procédé de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant.
WO1994020460A1 (fr) * 1993-03-11 1994-09-15 Smithkline Beecham Corporation Composes chimiques
US5554607A (en) * 1995-11-28 1996-09-10 American Home Products Corporation Use of 2-thioxo-imidazolin-4-one derivatives in the treatment of atherosclerosis

Also Published As

Publication number Publication date
EP0876354A1 (fr) 1998-11-11
JP2000514401A (ja) 2000-10-31
WO1997019931A1 (fr) 1997-06-05
CA2238812A1 (fr) 1997-06-05
AU1063497A (en) 1997-06-19

Similar Documents

Publication Publication Date Title
AR004781A1 (es) Derivados de 2-(sulfanil substituido)-3,5-dihidro-imidazol-4-ona y su uso en la preparacionn de medicamentos.
MEP24608A (en) Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same
DK1169298T3 (da) Farmaceutiske forbindelser
ES2158284T3 (es) Metil-fenil-oxazolidinonas quirales.
FI963169A0 (fi) Enkefalinaasin ja ACE:n inhibittoreina käyttökelpoisia uusia merkaptoasetyyliamido-1,3,4,5-tetrahydrobents/c/-atsepin-3-onidisulfidijohdannaisia
DE69728544D1 (de) Totalsynthese von acylfulvenen mit antitumorwirkung
DE69204041D1 (de) Thiazolidinverbindeungen, deren Herstellung und therapeutische Verwendung.
KR960007592A (ko) 신규한 피롤로카바졸
ATE249440T1 (de) Flüssige benzisochinoline derivate
ES551274A0 (es) Un procedimiento para la sintesis de derivados de imidazol.
NO971789D0 (no) Di-tert-butylfenolforbindelser med heterocyklisk enhet for anvendelse som antiinflammatoriske midler
AR004777A1 (es) Uso de derivados de 2-tioxo-imidazolidin-4-ona para la preparacion de medicamentos y medicamentos que los contiene.
FI894134A0 (fi) Disubstituerade bensylaminer, deras framstaellningsprocess, deras anvaendning som medicin och deras framstaellningsaemnen.
AR025951A1 (es) Derivados de 4-hicroxibifenil hidrazidas y métodos para preparar los derivados.
CO5150179A1 (es) Derivados de n-etilpirimidin o (piridin)-2-(1,2-benzoisoxa- zol-3-il)-octahidro-2h-pirido[1,2-a]pirazina y sus composiciones farmaceuticas
AR004691A1 (es) Nuevos derivados de [3-alcoxi-fenoxi-)-etil]-dialquilamina, una composicion farmaceutica que los comprende, su uso como anestesicos locales y unprocedimiento para su preparacion
DK0490816T3 (da) Fluorforbindelser som aromatase-inhibitorer.
FR2395998A1 (fr) Nouveaux derives de la thiazolidine et leur application dans le traitement de l'hypertension
ITMI920084A1 (it) Alchil derivati del trazodone
ES2045197T3 (es) N-substituidos-n-nitroso-aminoacetonitrilos, procedimiento para su fabricacion y utilizacion.
FI833784A0 (fi) 1,3,4,6,7,11b-hexahydro-7-aryl-2h-pyrazino/2,1-a/isokinoliner och foerfaranden foer framstaellning dessa
FI914715A0 (fi) Anvaendning av fosfonsyradiglycidylestrar som foernaetningsmedel vid framstaellning av hydrogel.
FI861934A0 (fi) Nya isoxazolderivat, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska preparat.
DK0379414T3 (da) Derivater af 1,8-benzonaphthyridin og fremstilling deraf
BR9912885A (pt) Derivado de 3-azabiciclo-[3.2.0]- heptano n-substituìdo